Literature DB >> 20081381

Family planning and HIV: strange bedfellows no longer.

Rose Wilcher, Willard Cates, Simon Gregson.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20081381      PMCID： PMC3516801          DOI： 10.1097/01.aids.0000363772.45635.35

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  30 in total

Review 1.  The contribution of sexual and reproductive health services to the fight against HIV/AIDS: a review.

Authors:  Ian Askew; Marge Berer
Journal:  Reprod Health Matters       Date:  2003-11

2.  Contraception's proved potential to fight HIV.

Authors:  H W Reynolds; M J Steiner; W Cates
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

3.  Integrating reproductive health: myth and ideology.

Authors:  L Lush; J Cleland; G Walt; S Mayhew
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

4.  Sexually transmitted diseases and family planning. Strange or natural bedfellows, revisited.

Authors:  W Cates
Journal:  Sex Transm Dis       Date:  1993 May-Jun       Impact factor: 2.830

5.  Sexually transmitted diseases and family planning. Strange or natural bedfellows?

Authors:  W Cates
Journal:  J Reprod Med       Date:  1984-05       Impact factor: 0.142

6.  Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group.

Authors:  R Martin; P Boyer; H Hammill; H Peavy; A Platzker; R Settlage; A Shah; R Sperling; R Tuomala; M Wu
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

7.  Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000.

Authors:  Annabel Desgrées-Du-Loû; Philippe Msellati; Ida Viho; Angèle Yao; Delphine Yapi; Pierrette Kassi; Christiane Welffens-Ekra; Laurent Mandelbrot; François Dabis
Journal:  Int J STD AIDS       Date:  2002-07       Impact factor: 1.359

8.  Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.

Authors:  Michael D Sweat; Kevin R O'Reilly; George P Schmid; Julie Denison; Isabelle de Zoysa
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

Review 9.  The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis.

Authors:  P Brocklehurst; R French
Journal:  Br J Obstet Gynaecol       Date:  1998-08

10.  Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.

Authors:  E J Abrams; P B Matheson; P A Thomas; D M Thea; K Krasinski; G Lambert; N Shaffer; M Bamji; D Hutson; K Grimm
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124
View more
  29 in total

1.  Contraceptive Practice in Sub-Saharan Africa.

Authors:  Amy O Tsui; Win Brown; Qingfeng Li
Journal:  Popul Dev Rev       Date:  2017-03-31

2.  Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.

Authors:  Quarraisha Abdool Karim; Ayesha B M Kharsany; Janet A Frohlich; Lise Werner; May Mashego; Mukelisiwe Mlotshwa; Bernadette T Madlala; Fanelesibonge Ntombela; Salim S Abdool Karim
Journal:  Int J Epidemiol       Date:  2010-11-03       Impact factor: 7.196

Review 3.  Family planning and the burden of unintended pregnancies.

Authors:  Amy O Tsui; Raegan McDonald-Mosley; Anne E Burke
Journal:  Epidemiol Rev       Date:  2010-06-22       Impact factor: 6.222

4.  Does integrating family planning into HIV care and treatment impact intention to use contraception? Patient perspectives from HIV-infected individuals in Nyanza Province, Kenya.

Authors:  Sara J Newmann; Daniel Grossman; Cinthia Blat; Maricianah Onono; Rachel Steinfeld; Elizabeth A Bukusi; Starley Shade; Craig R Cohen
Journal:  Int J Gynaecol Obstet       Date:  2013-08-06       Impact factor: 3.561

5.  Providers' views concerning family planning service delivery to HIV-positive women in Mozambique.

Authors:  Sarah R Hayford; Victor Agadjanian
Journal:  Stud Fam Plann       Date:  2010-12

6.  HIV status, fertility intentions, and contraception in the era of expanded access to antiretroviral therapy: A case study of rural Mozambique.

Authors:  Victor Agadjanian; Sarah R Hayford
Journal:  Glob Public Health       Date:  2016-12-29

7.  Pregnancy desire and dual method contraceptive use among people living with HIV attending clinical care in Kenya, Namibia and Tanzania.

Authors:  Gretchen Antelman; Amy Medley; Redempta Mbatia; Sherri Pals; Gilly Arthur; Sabina Haberlen; Marta Ackers; Batya Elul; Julie Parent; Anath Rwebembera; Lucy Wanjiku; Nicholas Muraguri; Justice Gweshe; Sandra Mudhune; Pamela Bachanas
Journal:  J Fam Plann Reprod Health Care       Date:  2015-01

8.  Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services.

Authors:  Angela Kaida; Fatima Laher; Steffanie A Strathdee; Deborah Money; Patricia A Janssen; Robert S Hogg; Glenda Gray
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

9.  Gendered power dynamics and women's negotiation of family planning in a high HIV prevalence setting: a qualitative study of couples in western Kenya.

Authors:  Elizabeth K Harrington; Shari Dworkin; Mellissa Withers; Maricianah Onono; Zachary Kwena; Sara J Newmann
Journal:  Cult Health Sex       Date:  2015-10-26

10.  Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda.

Authors:  Angela Kaida; Lynn T Matthews; Steve Kanters; Jerome Kabakyenga; Conrad Muzoora; A Rain Mocello; Jeffrey N Martin; Peter Hunt; Jessica Haberer; Robert S Hogg; David R Bangsberg
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.